Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
暂无分享,去创建一个
D R Hoover | J. Margolick | D. Vlahov | T. Quinn | T. Sterling | D. Hoover | J. Astemborski | T. Quinn | J Astemborski | D Vlahov | T C Quinn | J B Margolick | J. Astemborski | T R Sterling | D. Hoover
[1] A Munoz,et al. The Alive Study: A Longitudinal Study of HIV-1 Infection in Intravenous Drug Users: Description of Methods , 1991, NIDA research monograph.
[2] Hiv Survival,et al. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis , 2000, The Lancet.
[3] M. Salimans,et al. Rapid and simple method for purification of nucleic acids , 1990, Journal of clinical microbiology.
[4] Richard D Moore,et al. Lack of sex difference in CD4 to HIV-1 RNA viral load ratio , 1999, The Lancet.
[5] J. Margolick,et al. Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters. , 1999, The Journal of infectious diseases.
[6] T. Louis,et al. Survival and disease progression according to gender of patients with HIV infection. The Terry Beirn Community Programs for Clinical Research on AIDS. , 1994, JAMA.
[7] R. Hoffman,et al. Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[8] Roel A. Coutinho,et al. Time from HIV-1 seroconversion to Aids and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis: collaborative Group on Aids incubation and HIV survival including the CASCADE EU concerted action , 2000 .
[9] R H Lyles,et al. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. , 2000, The Journal of infectious diseases.
[10] J. D. Malone,et al. Human immunodeficiency virus RNA levels in US adults: a comparison based upon race and ethnicity. , 1997, The Journal of infectious diseases.
[11] S. Hammer,et al. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team. , 1996, The New England journal of medicine.
[12] D. van Strijp,et al. The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course? , 1994, Virology.
[13] J. Mellors,et al. Quantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion , 1995, Annals of Internal Medicine.
[14] L A Kalish,et al. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV study. , 1999, AIDS.
[15] R. Hogg,et al. Serum levels of human immunodeficiency virus type 1 (HIV-1) RNA after seroconversion: a predictor of long-term mortality in HIV infection. , 1997, Journal of Infectious Diseases.
[16] Rainer Weber,et al. Sex differences in HIV-1 viral load and progression to AIDS , 1999, The Lancet.
[17] P. Kvale,et al. Gender is not a factor in serum human immunodeficiency virus type 1 RNA levels in patients with viremia , 1996, Journal of clinical microbiology.
[18] D. Burke,et al. Serum levels of virus burden in early-stage human immunodeficiency virus type 1 disease in women. , 1997, The Journal of infectious diseases.
[19] Roger Detels,et al. Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection , 1997, Annals of Internal Medicine.
[20] J. Margolick,et al. Association of race and gender with HIV-1 RNA levels and immunologic progression. , 2000 .
[21] J J Goedert,et al. Natural history of HIV-1 cell-free viremia. , 1995, JAMA.
[22] P Pezzotti,et al. Longitudinal human immunodeficiency virus type 1 load in the italian seroconversion study: correlates and temporal trends of virus load. , 1999, The Journal of infectious diseases.
[23] J. Margolick,et al. Sex differences in HIV-1 viral load and progression to AIDS , 1998, The Lancet.
[24] D. Vlahov,et al. Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS studies. AIDS Link to Intravenous Experiences. Italian Seroconversion Study. , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[25] K Henry,et al. The Case for More Cautious, Patient-Focused Antiretroviral Therapy , 2000, Annals of Internal Medicine.
[26] J. Margolick,et al. Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[27] R. Chaisson,et al. Race, sex, drug use, and progression of human immunodeficiency virus disease. , 1995, The New England journal of medicine.
[28] M A Fischl,et al. Antiretroviral Therapy in Adults Updated Recommendations of the International AIDS Society–USA Panel , 2000 .
[29] J. Margolick,et al. Quality control in the flow cytometric measurement of T-lymphocyte subsets: the multicenter AIDS cohort study experience. The Multicenter AIDS Cohort Study Group. , 1990, Clinical immunology and immunopathology.